Healthy men needed to track Drug's path out of the body
NCT ID NCT07612306
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This early-stage study looks at how a drug called Flonoltinib maleate (being developed for a bone marrow condition) is processed and removed from the body. Six healthy adult men will take a single dose, and researchers will measure the drug and its breakdown products in blood, urine, and stool. The goal is to understand excretion routes and safety, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MB are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for myelofibrosis patients who failed standard therapy
- Massive new study aims to unlock secrets of rare blood cancers
- New hope for advanced cancers? JAB-8263 enters human testing
- New pill aims to shrink spleen in bone marrow cancer
- Hope for myelofibrosis patients: new drug combo aims to shrink spleens and ease symptoms